Granulocyte defects and opioid receptors in chronic exposure to heroin or methadone in humans

Int J Immunopharmacol. 1994 Nov;16(11):959-67. doi: 10.1016/0192-0561(94)90049-3.

Abstract

In order to elucidate better the immunological effect of opioid abuse in the absence of HIV infection as a confounding factor, granulocyte function was investigated in three groups of HIV-negative subjects, including 20 active parenteral heroin abusers (H), 20 long-term methadone-maintained former opiate abusers (M) and 20 healthy controls (C). Chemotaxis to N-formyl methionyl-leucyl-phenylalanine (fMLP), casein and activated plasma were markedly and similarly reduced (approx. 50%) in both H and M groups, as was true for superoxide production after fMLP and PMA stimulation, 47% decrease of C values. Polymorphonuclear (PMN) of H and M subjects also exhibited a very marked and similar reduction in the expression of CD11b/CD18 integrin receptors after fMLP treatment, with values that were less than 10% of those in controls, as observed by flow cytometry. In parallel, PMN of H and M individuals presented an approximately four-fold increase in opioid receptors numbers compared to controls, a significant inverse correlation existing between the increase in opiate receptors and defective chemotaxis. The possible mechanism underlying the observed changes in PMN of H and M individuals is discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cells, Cultured
  • Chemotaxis, Leukocyte / drug effects
  • Female
  • Granulocytes / drug effects*
  • Heroin Dependence / immunology*
  • Heroin Dependence / rehabilitation
  • Humans
  • Macrophage-1 Antigen / blood
  • Male
  • Methadone / adverse effects
  • Methadone / pharmacology*
  • Receptors, Opioid / drug effects*
  • Superoxides / blood

Substances

  • Macrophage-1 Antigen
  • Receptors, Opioid
  • Superoxides
  • Methadone